LINNC online 🧠

A reference source for the entire Interventional NeuroRadiology, Neurology and NeuroSurgery community

[LINNC online 🧠 @LINNConline]

🆕 The DISCOUNT trial: key insights at a glance.

👉 Essential findings.

Discover this study and many other landmark neurointerventional trials in the LINNC Trials Book, download it for free: https://t.co/b2J4H6BjWI

[LINNC online 🧠 @LINNConline]

How can simulation technology transform neurointerventional workflows?

Razvan Radu and Sandor Nardai share their experience with patient-specific predictive models, discussing how simulation can:
🔹 Optimize intrasaccular device sizing
🔹 Shorten learning curves for large clinical teams
🔹 Improve procedural planning and prevent complications in elective aneurysm cases

🎥 Get practical takeaways from the experts: https://t.co/d2XsTlLnRF

@SimAndCure

[LINNC online 🧠 @LINNConline]

🧠 Could hydrophilic polymer coatings (HPC) change antiplatelet management after flow diversion?

Markus Holtmannspötter and Laurent Pierot discuss the landmark one-year results of the COATING randomized controlled trial. The study demonstrated that HPC under single antiplatelet therapy (SAPT) shows no statistically significant difference in the safety profile compared with standard treatment.

These findings suggest a potential alternative to dual antiplatelet therapy (DAPT), with SAPT showing no increase in the thromboembolic risk.

🎥 Take a closer look at the clinical implications of the COATING trial: https://t.co/k4f8xer3yE

[LINNC online 🧠 @LINNConline]

🧠 Simulation: a new standard for neurointerventional training?

From mastering complex aneurysm cases to accelerating the learning curve of international fellows, simulation is becoming an essential part of modern neurointerventional education.

In this expert interview, Vincent Costalat and Daniel Mantilla discuss how simulation is transforming:
✅ Training and education
✅ Knowledge transfer
✅ Procedural preparation

Join the discussion 👉 https://t.co/LpqXEiz14b

@SimAndCure

[LINNC online 🧠 @LINNConline]

How is intrasaccular therapy evolving in the treatment of intracranial aneurysms?

Join Pascal Jabbour and Jens Fiehler as they review the latest clinical evidence supporting the Contour Neurovascular System™
👉 https://t.co/YPp6MigitC

Key insights from the discussion include:
🔹 Preliminary results from the NECC trial showing promising safety and occlusion rates
🔹 Findings from the CONTRA study supporting the use of the device in ruptured aneurysms, with high efficacy and structural stability
🔹Outlook into the upcoming DELIVER-I Registry, designed to generate real-world evidence on the performance of Contour, Neqstent, and Trenza in everyday clinical practice

Watch the interview to explore further clinical insights!

[LINNC online 🧠 @LINNConline]

Relive #LINNCParis 2026 through the official aftermovie.

Over three days, the global neurointerventional community came together for live cases streamed from six countries, high-level scientific discussions, and continuous exchange between leading experts.

This edition also marked a celebration of Professor Jacques Moret, honoring his vision and his lasting impact on the field and the LINNC community.

With Laurent Spelle and @vitorpereiracan on stage, animating the community throughout the courses, LINNC Paris once again confirmed its role as a meeting point for the international neurointerventional community.

[LINNC online 🧠 @LINNConline]

🧠 Beyond the braid: what's really driving the new Surpass Elite® Flow Diverter's performance? ▶️https://t.co/IQTADJ3vD4

In this interview, Emanuele Orru and Naga Kandasamy present and discuss the latest insights from the global multi-center Surpass ELITE-REAL study and share their experience with the new-generation device.

Key topics discussed:
✔️ How have the implant design enhancements simplified sizing and deployment?
✔️ Early safety and efficacy signals: ~90% adequate occlusion at 6 months, very low in-stent stenosis, no device-related complications
✔️ What's next: subgroup analyses on small vs. giant aneurysms, and a dedicated ruptured-aneurysm dataset

▶️ Watch now!

[LINNC online 🧠 @LINNConline]

A new Trial Spotlight is here!

🔬 What question did the ESCAPE-MeVO study aim to answer, and what was the key result?

Browse the slides for a quick, highly concise overview.

📘 To go further, download the LINNC Trials Book, the 2026 edition is available here➡️https://t.co/NV602v5KWj

[LINNC online 🧠 @LINNConline]

🧠 Can dedicated neck bridging devices change the game for wide-neck bifurcation aneurysms?

Raphaël Blanc and Waleed Butt explore the clinical experience with eCLIPs™, including promising safety data from the EESIS-FR study and its potential advantages in complex anatomies and recurrent aneurysms.

Join this expert discussion: https://t.co/v3QS5S3pjX

💡 Topics covered:
- Early EESIS-FR outcomes
- Technical aspects of eCLIPs™ deployment
- Treatment of distal bifurcation aneurysms
- Management of recurrences after intrasaccular devices

[LINNC online 🧠 @LINNConline]

🔔 More than 80% of pulsatile tinnitus cases are associated with venous sinus stenosis.

Yet, venous stenting still largely relies on off-label carotid or peripheral devices.

Could dedicated venous stents change clinical practice❓

Join Dr. Raphael Blanc as he presents the first clinical experience in France with the Viva Stent and shares initial results, exploring how a dedicated venous stent could improve safety and procedural success in pulsatile tinnitus.

🎥 Watch the replay: https://t.co/Gwudc4oBhF

[LINNC online 🧠 @LINNConline]

Neurointerventional practice evolves fast, your references should too!

The 2026 edition of the LINNC Trials Book, edited by @DanielVelaMD and Laurent Spelle, has just been updated with more than 20 new trials across key sections.

It brings together the key evidence shaping clinical decision-making today in a concise, highly practical format.

📘 Download the 2026 edition for free: https://t.co/U23yts10rm

[LINNC online 🧠 @LINNConline]

Mechanical thrombectomy now achieves excellent reperfusion rates, but does angiographic success always mean tissue reperfusion?▶️https://t.co/bO7x7NVmWw

In this interview, @DoctorGaldamez and @sujijantaratMD discuss the rationale behind the CHOICE-2 trial and how adjunctive intra-arterial alteplase may help improve microvascular perfusion after successful thrombectomy.

Watch now to discover the patient selection criteria and key findings from this landmark study!

[LINNC online 🧠 @LINNConline]

A fast-paced closing day: mevo debate, ct vs mri in the era of ai & new frontiers of mma

The final day at #LINNCParis 2026 pushed the boundaries of neurointervention, through complex cases and impactful lectures.

Dive into Eileen Liu's in-depth report covering the latest randomized trial data on Medium Vessel Occlusions (MeVO), the intense AI-driven debate of CT vs. MRI in acute stroke care, and how to improve outcomes 10 years after thrombectomy.

Browse article 👉 https://t.co/ldnWtvmb0B

[LINNC online 🧠 @LINNConline]

Thank you all for an incredible #LINNCParis 2026.

This final day concluded an exceptional edition, marked by strong scientific exchange and memorable moments.

Your energy and expertise made this meeting truly special.

Congratulations to the Best Case Award winner, Nikola Serman (Croatia), for his case:
“Lips to die for: invasive sino-orbital aspergillosis after dermal filler injections presenting with cavernous sinus thrombosis, ICA stenosis, and pseudoaneurysm.”

See you at LINNC Paris 2027, from Wednesday 2 to Friday 4.

[LINNC online 🧠 @LINNConline]

When technical mastery meets patient safety

What happens when global expert teams from three continents share their angiosuites? @DanielVelaMD breaks down the most instructive live cases of the Course, ranging from challenging flow diversion maneuvers to advanced intrasaccular innovations and the clinical introduction of high-resolution neuro-OCT imaging.

Read the report 👉 https://t.co/goPTNnlfEd

[LINNC online 🧠 @LINNConline]

🎥 Final day of #LINNCParis 2026 with the social media team.

@sujijantaratMD and @neurofox share their impressions of two key highlights: the MMA round table and the “Controversy Session”, both major moments of this closing day.

A strong finish to an intense and inspiring edition.

[LINNC online 🧠 @LINNConline]

🎥 A look back at Day 2 of #LINNCParis 2026 with the social media team.

@sujijantaratMD and @DanielVelaMD share what stood out most from a truly exceptional day: live international cases, engaging discussions, and great energy throughout the sessions.

[LINNC online 🧠 @LINNConline]

Thank you, Prof. Jacques Moret!

At the end of the second day of LINNC Paris 2026, we had the honor of celebrating Professor Jacques Moret as he steps down from his role as Course Director of LINNC.

Some moments remind us of the strength of a community built on gratitude, transmission, and shared passion. This was one of those moments.

Surrounded by friends, colleagues, and members of the community, we had the privilege of honoring a truly exceptional figure whose vision and dedication have profoundly shaped our field.

On behalf of the entire community, thank you. Your commitment, generosity, and leadership have inspired generations, and we are deeply grateful for everything you have built and shared.

[LINNC online 🧠 @LINNConline]

What Shaped the opening day at hashtag#LINNCParis 2026? Dive into Emanuele Orru's Perspective

From CSF venous fistula treatment to complex AVM decision-making, evolving aneurysm strategies, and hands-on discussions around complications and device innovation, Day 1 highlighted both the growing sophistication of the field and the increasing importance of clinical judgment.

Beyond technical excellence, the discussions consistently returned to a central theme: when multiple treatment options exist, the quality of decision-making becomes more critical than ever.

Get his view 👉 https://t.co/yobySdoeaL